Skip to content

Clinical trials

Completed Leukemia, Myeloid, Chronic-Phase trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Status: Completed Clear all

272 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200020
200112
200217
200319
200416
200521
200611
200715
200816
20099
20105
20116
20127
20137
20142
20153
20161
20173
20182
20193
20204
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed272

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center42
Memorial Sloan Kettering Cancer Center15
National Cancer Institute (NCI)15
Case Comprehensive Cancer Center12
M.D. Anderson Cancer Center12
Roswell Park Cancer Institute11
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins11
Bristol-Myers Squibb8
City of Hope Medical Center8
University of California, San Francisco7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase272
Leukemia, Myeloid, Accelerated Phase177
Precursor Cell Lymphoblastic Leukemia-Lymphoma173
Leukemia171
Leukemia, Lymphocytic, Chronic, B-Cell153
Leukemia, Myeloid, Acute148
Blast Crisis146
Burkitt Lymphoma144
Lymphoma, Follicular141
Lymphoma, Large B-Cell, Diffuse141

Trials

Showing 26 to 50 of 272. Each trial links to its page on Pharma Observatory.

172 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.